Nasus Pharma: MACD Golden Cross, RSI Oversold on 15-Minute Chart

According to Nasus Pharma's 15-minute chart, a bullish signal has been triggered by the MACD Golden Cross, coupled with an oversold RSI reading of 23.45 as of January 23, 2026. This suggests that the stock price has the potential to continue its upward trajectory, having dropped precipitously and fallen below its fundamental support level.